Annals of the rheumatic diseases

• Latest
• Best
• Search…

• Ann. Rheum. Dis. · May 2020

  Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon et al.

  no abstract available

  expand abstract… or just mark as read…

• Ann. Rheum. Dis. · May 2020

  Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al.

  no abstract available

  read on… mark as read…

• Ann. Rheum. Dis. · May 2020

  Letter

  Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.

  no abstract available

  read more… mark as read…

• Ann. Rheum. Dis. · May 2020

  Letter

  Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.

  no abstract available

  read more… or not…

• Ann. Rheum. Dis. · May 2020

  Review

  Disruptive innovation in rheumatology: new networks of global public-private partnerships are needed to take advantage of scientific progress.

  no abstract available

  expand abstract… or just mark as read…